REFERENCES

1. Rebbeck TR, Haas GP. Temporal trends and racial disparities in global prostate cancer prevalence. Can J Urol 2014;21:7496-506.

2. Wong MCS, Goggins WB, Wang HHX, Fung FDH, Leung C, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol 2016;70:862-74.

3. Rebbeck TR. Conquering cancer disparities: new opportunities for cancer epidemiology, biomarker, and prevention research. Cancer Epidemiol Biomarkers Prev 2006;15:1569-71.

4. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.

5. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate 1990;16:39-48.

6. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-71.

7. Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol 2006;175:S19-24.

8. Gong EM, Gerber GS. Saw palmetto and benign prostatic hyperplasia. Am J Chin Med 2004;32:331-8.

9. Lee KL, Peehl DM. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 2004;172:1784-91.

10. Li W, Wu C-L, Febbo PG, Olumi AF. Stromally expressed c-jun regulates proliferation of prostate epithelial cells. Am J Pathol 2007;171:1189-98.

11. Alcaraz A, Hammerer P, Tubaro A, Schröder FH, Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009;55:864-73.

12. Dai X, Fang X, Ma Y, Xianyu J. Benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer. A meta-analysis of observational studies. Medicine (Baltimore) 2016;95:e3493.

13. Guess HA. Benign Prostatic Hyperplasia and Prostate Cancer. Epidemiol Rev 2001;23:152-8.

14. Aslam R, Neubauer S. Dairy foods, milk, calcium, and risk of prostate cancer. Oncol Nutr Connect 2013;21:1,3-10.

15. Zaichick V, Zaichick S. Dietary intake of minerals and prostate cancer: insights into problem based on the chemical element contents in the prostate gland. J Aging Res Clin Practice 2015;4:164-71.

16. Zaichick V, Zaichick S, Wynchank S. Intracellular zinc excess as one of the main factors in the etiology of prostate cancer. J Anal Oncol 2016;5:124-31.

17. Zaichick V, Zaichick S, Rossmann M. Intracellular calcium excess as one of the main factors in the etiology of prostate cancer. AIMS Mol Sci 2016;3:635-47.

18. Tavani A, Longoni E, Bosetti C, Maso LD, Polesel J, et al. Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: a case-control study from Italy. Eur Urol 2006;50:549-54.

19. Zaichick V. Medical elementology as a new scientific discipline. J Radioanal Nucl Chem 2006;269:303-9.

20. Ektessabi A, Shikine S, Kitamura N, Rokkum M, Johansson C. Distribution and chemical states of iron and chromium released from orthopedic implants into human tissues. X-Ray Spectrom 2001;30:44-8.

21. Yoshida S, Ektessabi A, Fujisawa S. XAFS spectroscopy of a single neuron from a patient with Parkinson’s disease. J Synchrotron Radiat 2001;8:998-1000.

22. Isaacs JT. Prostatic structure and function in relation to the etiology of prostatic cancer. Prostate 1983;4:351-66.

23. Zaichick V, Zaichick S. Role of zinc in prostate cancerogenesis. In: Anke M, editor. Mengen und Spurenelemente, 19 Arbeitstagung. Jena: Friedrich-Schiller-Universität; 1999. pp. 104-15.

24. Zaichick V. INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. J Radioanal Nucl Chem 2004;262:229-34.

25. Zaichick S, Zaichick V. The Br, Fe, Rb, Sr, and Zn content and interrelation in intact and morphologic normal prostate tissue of adult men investigated by energy dispersive X-ray fluorescent analysis. X-Ray Spectrom 2011;40:464-9.

26. Zaichick S, Zaichick V. INAA application in the age dynamics assessment of Br, Ca, Cl, K, Mg, Mn, and Na content in the normal human prostate. J Radioanal Nucl Chem 2011;288:197-202.

27. Zaichick V, Nosenko S, Moskvina I. The effect of age on 12 chemical element contents in intact prostate of adult men investigated by inductively coupled plasma atomic emission spectrometry. Biol Trace Elem Res 2012;147:49-58.

28. Zaichick V, Zaichick S. Age-related histological and zinc content changes in adult nonhyperplastic prostate glands. Age (Dordr) 2014;36:167-81.

29. Zaichick S, Zaichick V. The effect of age on Ag, Co, Cr, Fe, Hg, Sb, Sc, Se, and Zn contents in intact human prostate investigated by neutron activation analysis. Appl Radiat Isot 2011;69:827-33.

30. Zaichick V, Zaichick S. The effect of age on Br, Ca, Cl, K, Mg, Mn, and Na mass fraction in pediatric and young adult prostate glands investigated by neutron activation analysis. Appl Radiat Isot 2013;82:145-51.

31. Zaichick V, Zaichick S. INAA application in the assessment of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn mass fraction in pediatric and young adult prostate glands. J Radioanal Nucl Chem 2013;298:1559-66.

32. Zaichick V, Zaichick S. NAA-SLR and ICP-AES Application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands. Biol Trace Elem Res 2013;156:357-66.

33. Zaichick V, Zaichick S. Use of neutron activation analysis and inductively coupled plasma mass spectrometry for the determination of trace elements in pediatric and young adult prostate. Am J Analyt Chem 2013;4:696-706.

34. Zaichick V, Zaichick S. INAA application in the assessment of chemical element mass fractions in adult and geriatric prostate glands. Appl Radiat Isot 2014;90:62-73.

35. Zaichick V, Zaichick S. Determination of trace elements in adults and geriatric prostate combining neutron activation with inductively coupled plasma atomic emission spectrometry. Open J Biochem 2014;1:16-33.

36. Zaichick V, Zaichick S. Use of INAA and ICP-MS for the assessment of trace element mass fractions in adult and geriatric prostate. J Radioanal Nucl Chem 2014;301:383-97.

37. Zaichick V. The variation with age of 67 macro- and microelement contents in nonhyperplastic prostate glands of adult and elderly males investigated by nuclear analytical and related methods. Biol Trace Elem Res 2015;168:44-60.

38. Zaichick V, Zaichick S. Androgen-dependent chemical elements of prostate gland. Androl Gynecol:. Curr Res 2014;2:1-15.

39. Zaichick V, Zaichick S. Differences and relationships between morphometric parameters and zinc content in nonhyperplastic and hyperplastic prostate glands. Br J Med Med Res 2015;8:692-706.

40. Zaichick V. The prostatic urethra as a Venturi effect urine-jet pump to drain prostatic fluid. Med Hypotheses 2014;83:65-8.

41. Mackenzie AR, Hall T, Whitmore WF Jr. Zinc content of expressed human prostate fluid. Nature (London) 1962;193:72-3.

42. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Values for zinc in whole semen, fraction of split ejaculate and expressed prostatic fluid. Urology 1980;16:478-80.

43. Zaichick V, Tsyb A, Dunchik VN, Sviridova TV. .

44. Zaichick V, Sviridova T, Zaichick S. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma, and cancer. Int Urol Nephrol 1996;28:687-94.

45. Zaichick V. Applications of synthetic reference materials in the medical Radiological Research Centre. Fresenius J Anal Chem 1995;352:219-23.

46. Romics I, Bach D. Zn, Ca and Na levels in the prostatic secretion of patients with prostatic adenoma. Int Urol Nephrol 1991;23:45-9.

47. Gómes Y, Arocha F, Espinoza F, Fernandez D, Vásquez A, et al. Niveles de zinc en líquido prostático de pacientes con patologías de próstata. Invest Clin 2007;48:287-94.

48. Zaichick V, Sviridova T, Zaichick S. Zinc in human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 1997;29:565-74.

49. Kavanagh JP, Darby C. The interrelationships between acid phosphatase, aminopeptidase, diamine oxidase, citric acid, β-glucuronidase, pH and zinc in human prostate fluid. Int J Androl 1982;5:503-12.

50. Huggins C, Scott W, Heinen JH. Chemical composition of human semen and of the secretion of the prostate and seminal vesicles. Amer J Physiol 1942;136:467-73.

51. Zaichick V. Sampling, sample storage and preparation of biomaterials for INAA in clinical medicine, occupational and environmental health. Harmonization of health-related environmental measurements using nuclear and isotopic techniques. Vienna: IAEA; 1997. pp. 123-33.

52. Zaichick V, Zaichick S. A search for losses of chemical elements during freeze-drying of biological materials. J Radioanal Nucl Chem 1997;218:249-53.

53. Zaichick V. Losses of chemical elements in biological samples under the dry aching process. Trace Elements in Medicine 2004;5:17-22.

54. Zaichick S, Zaichick V. Method and portable facility for energy-dispersive X-ray fluorescent analysis of zinc content in needle-biopsy specimens of prostate. X-Ray Spectrom 2010;39:83-9.

55. Zaichick V, Zaichick S, Davydov G. Method and portable facility for measurement of trace element concentration in prostate fluid samples using radionuclide-induced energy-dispersive X-ray fluorescent analysis. Nucl Sci Tech 2016;27:1-8.

56. Moore RA, Miller ML, Mc Lellan A. The chemical composition of prostatic secretion in relation to benign hypertrophy of the prostate. J Urol 1941;46:132-7.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/